The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
The presence of persistent high‐risk hpv genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months
Abstract
To evaluate the clinical significance of HPV genotyping for the prediction of progressive cervical intraepithelial neoplasia (CIN) in women with cytomorphologically abnormal smears, a prospective, blind, non‐intervention study was performed. A total of 342 patients screened with cytomorphologically abnormal cervical smears were monitored every 3–4 months by cervical cytology, colposcopy and HPV testing using PCR. Women with progressive CIN disease were defined as patients developing lesions with a colposcopic impression of CIN III over more than 2 quadrants or resulting in a cytological smear equivalent to Pap 5. These patients were subsequently treated according to standard procedures. If any doubt arose about the true status of the patients (n = 75) these patients were censored and biop‐sied. The mean follow‐up time was 16.5 months (range 3–36 months). Nineteen women showed progressive CIN disease and all appeared to be continuously HPV‐positive from the start of the study. At biopsy, all these patients were histologically classified as CIN III. Seventeen of these women were positive for high‐risk HPV types. Two cases were classified as still unidentified HPV. No progression was seen in the absence of HPV DNA or in the presence of low‐risk HPV types. In life‐table analysis the cumulative rate of progressive, histologically verified CIN disease was 17% after 36 months. Further analyses showed that other risk factors such as age, sexarche, number of sexual partners or smoking hardly influenced the effect of HPV on progression. The results show that the continuous presence of high‐risk HPV types in women with cytomorphologically abnormal smears is a strong marker for progressive CIN disease. ©1995 Wiley Liss. Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schiffman, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.12.958 · Cited by 1,210
Bauer, H. M. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460040048027 · Cited by 952
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 943
Human papillomaviruses in the pathogenesis of anogenital cancer
zur Hausen, H. (1991) · Virology · doi:10.1016/0042-6822(91)90816-t · Cited by 847
LORINCZ, A. T., REID, R., JENSON, B. A., GREENBERG, M. D., LANCASTER, W., & KURMAN, R. J. (1992) · Obstetrics & Gynecology · doi:10.1097/00006250-199203000-00002 · Cited by 775
Mills, J. M., & Stier, E. A. (2021) · 50 Studies Every Obstetrician-Gynecologist Should Know · doi:10.1093/med/9780190947088.003.0031 · Cited by 756
The Papanicolaou Test for Cervical Cancer Detection: A Triumph and a Tragedy
Koss, L. G. (1989) · JAMA · doi:10.1001/jama.1989.03420050087046 · Cited by 645
Munoz, N., Bosch, F. X., de Sanjose, S., Tafur, L., Izarzugaza, I., Gili, M., Viladiu, P., Navarro, C., Martos, C., Ascunce, N., et al. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520513 · Cited by 568
A follow-up study of patients with cervical dysplasia
Richart, R. M., & Barron, B. A. (1969) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(69)90268-3 · Cited by 391
Melkert, P. W. J., van den Brule, A. J. C., Risse, E. K. J., van Diest, P. J., Meijer, C. J. L. M., Walboomers, J. M. M., Helmerhorst, T., Hopman, E., Bleker, O. P., & Schipper, M. E. I. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530609 · Cited by 281
Self-citation
Cited by
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
Self-citationNobbenhuis, M. A., Walboomers, J. M., Helmerhorst, T. J., Rozendaal, L., Remmink, A. J., Risse, E. K., van der Linden, H. C., Voorhorst, F. J., Kenemans, P., & Meijer, C. J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12490-x · Cited by 685
Self-citationGravitt, P. E., Peyton, C. L., Apple, R. J., & Wheeler, C. M. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.3020-3027.1998 · Cited by 646
Immune responses to human papillomavirus
Stanley, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.002 · Cited by 586
Jacobs, M. V., Snijders, P. J., van den Brule, A. J., Helmerhorst, T. J., Meijer, C. J., & Walboomers, J. M. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.3.791-795.1997 · Cited by 568
Self-citationProjected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
Goldie, S. J., Kohli, M., Grima, D., Weinstein, M. C., Wright, T. C., Bosch, F. X., & Franco, E. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh104 · Cited by 539
Rijkaart, D. C., Berkhof, J., Rozendaal, L., van Kemenade, F. J., Bulkmans, N. W., Heideman, D. A., Kenter, G. G., Cuzick, J., Snijders, P. J., & Meijer, C. J. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70296-0 · Cited by 515
Self-citationClavel, C., Masure, M., Bory, J.-P., Putaud, I., Mangeonjean, C., Lorenzato, M., Nazeyrollas, P., Gabriel, R., Quereux, C., & Birembaut, P. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1845 · Cited by 465
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems
Qu, W., Jiang, G., Cruz, Y., Chang, C. J., Ho, G. Y., Klein, R. S., & Burk, R. D. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.6.1304-1310.1997 · Cited by 463
Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis?
Pett, M., & Coleman, N. (2007) · The Journal of Pathology · doi:10.1002/path.2192 · Cited by 451
Regression of low-grade squamous intra-epithelial lesions in young women
Moscicki, A.-B., Shiboski, S., Hills, N. K., Powell, K. J., Jay, N., Hanson, E. N., Miller, S., Canjura-Clayton, L. K., Farhat, S., Broering, J. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17354-6 · Cited by 448
Dalstein, V., Riethmuller, D., Prétet, J., Le Bail Carval, K., Sautière, J., Carbillet, J., Kantelip, B., Schaal, J., & Mougin, C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11222 · Cited by 435
Sherman, M. E., Lorincz, A. T., Scott, D. R., Wacholder, S., Castle, P. E., Glass, A. G., Mielzynska-Lohnas, I., Rush, B. B., & Schiffman, M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.1.46 · Cited by 430
Goldie, S. J., Kuhn, L., Denny, L., Pollack, A., & Wright, T. C. (2001) · JAMA · doi:10.1001/jama.285.24.3107 · Cited by 335
Jacobs, M. V., de Roda Husman, A. M., van den Brule, A. J., Snijders, P. J., Meijer, C. J., & Walboomers, J. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.4.901-905.1995 · Cited by 323
Self-citationMolano, M. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg171 · Cited by 315
Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer
Mandelblatt, J. S. (2002) · JAMA · doi:10.1001/jama.287.18.2372 · Cited by 308
Smith, J. S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.21.1604 · Cited by 278
Opalka, D., Lachman, C. E., MacMullen, S. A., Jansen, K. U., Smith, J. F., Chirmule, N., & Esser, M. T. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.1.108-115.2003 · Cited by 276
Bulkmans, N. W. J., Rozendaal, L., Snijders, P. J. F., Voorhorst, F. J., Boeke, A. J. P., Zandwijken, G. R. J., van Kemenade, F. J., Verheijen, R. H. M., v Groningen, K., Boon, M. E., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20076 · Cited by 269
Self-citationKim, J. J. (2002) · JAMA · doi:10.1001/jama.287.18.2382 · Cited by 269
Deacon, J. M., Evans, C. D., Yule, R., Desai, M., Binns, W., Taylor, C., & Peto, J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1523 · Cited by 263
Tota, J. E., Chevarie-Davis, M., Richardson, L. A., deVries, M., & Franco, E. L. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.08.017 · Cited by 261
van Duin, M., Snijders, P. J. F., Schrijnemakers, H. F. J., Voorhorst, F. J., Rozendaal, L., Nobbenhuis, M. A. E., van den Brule, A. J. C., Verheijen, R. H. M., Helmerhorst, T. J., & Meijer, C. J. L. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10232 · Cited by 260
Self-citationGoldie, S. J., Grima, D., Kohli, M., Wright, T. C., Weinstein, M., & Franco, E. (2003) · International Journal of Cancer · doi:10.1002/ijc.11334 · Cited by 209
Smith, J. S., Muñoz, N., Herrero, R., Eluf‐Neto, J., Ngelangel, C., Franceschi, S., Bosch, F. X., Walboomers, J. M. M., & Peeling, R. W. (2002) · The Journal of Infectious Diseases · doi:10.1086/338569 · Cited by 171
Self-citationMultiparameter calibration of a natural history model of cervical cancer
Kim, J. J., Kuntz, K. M., Stout, N. K., Mahmud, S., Villa, L. L., Franco, E. L., & Goldie, S. J. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm086 · Cited by 161
Kraus, I., Molden, T., Holm, R., Lie, A. K., Karlsen, F., Kristensen, G. B., & Skomedal, H. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.4.1310-1317.2006 · Cited by 123
Stevens, M. P., Garland, S. M., & Tabrizi, S. N. (2008) · Journal of Virological Methods · doi:10.1016/j.jviromet.2007.09.018 · Cited by 52
Metadata
- Authors
- Remmink, A. J., Walboomers, J. M. M., Helmerhorst, T. J. M., Voorhorst, F. J., Rozendaal, L., Risse, E. K. J., Meijer, C. J. L. M., & Kenemans, P.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1995-05-04
- Volume
- 61
- Issue
- 3
- Pages
- 306-311
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2009334997
- Cited by
- 368
- References
- 18
- FWCI
- 15.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.